Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes

Oncogene volume 20, pages 7287–7291 (2001)Cite this article

Abstract

Chromosomal translocations, leading to gene rearrangements that generate chimerical proteins, represent one of the initiating events of leukemia. Preleukemia cells eventually develop into overt leukemia by occurrence of secondary genetic alterations (tumor progression). The physiopathology of leukemia has made considerable progress during the last two decades, due to molecular biology investigations on the role played by the altered genes, during neoplasic hemopoiesis. In vitro studies have been facilitated by the establishment of stable leukemia cell lines bearing these gene rearrangements and secondary gene mutations. Investigations on acute promyelocytic leukemia (APL) have benefited from maturation sensitive and resistant cell lines (NB4 and UF-1) derived from APL patient's leukemia cells and bearing the t(15;17). The information concerning the NB4 cell line (responsiveness to retinoid/rexinoid, cAMP, arsenic, mutations causing resistance) is spread in an abundant literature. In this paper, we briefly recapitulate the cellular and molecular features of this cell line and its subclones with the aim of facilitating investigators in their choice of the most appropriate tool for their studies. As redundancy of several names given to NB4 sublines has sometimes created difficulties, we propose a nomenclature for the various NB4 sublines that most investigators certainly would be agreed with.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Benoit G, Altucci L, Flexor M, Ruchaud S, Lillehaug J, Raffelsberger W, Gronemeyer H, Lanotte M . 1999 EMBO J. 18: 7011–7018

  • Benoit GR, Flexor M, Besancon F, Altucci L, Rossin A, Hillion J, Balajthy Z, Legres L, Segal-Bendirdjian E, Gronemeyer H, Lanotte M . 2001 Mol. Endocrinol. 15: 1154–1169

  • Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, Han ZG, Ni JH, Shi GY, Jia PM, Liu MM, He KL, Niu C, Ma J, Zhang P, Zhang TD, Paul P, Naoe T, Kitamura K, Miller W, Waxman S, Wang ZY, de Thé H, Chen SJ, Chen Z . 1997 Blood 89: 3345–3353

  • Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z . 1996 Blood 88: 1052–1061

  • Dermime S, Grignani F, Clerici M, Nervi C, Sozzi G, Talamo GP, Marchesi E, Formelli F, Parmiani G, Pelicci PG . 1993 Blood 82: 1573–1577

  • Dermime S, Grignani F, Rogaia D, Liberatore C, Marchesi E, Gambacorti-Passerini C . 1995 Leuk. Lymphoma 16: 289–295

  • Duprez E, Lillehaug JR, Gaub MP, Lanotte M . 1996a Oncogene 12: 2443–2450

  • Duprez E, Lillehaug JR, Naoe W, Lanotte M . 1996b Oncogene 12: 2451–2459

  • Duprez E, Benoit G, Flexor M, Lillehaug JR, Lanotte M . 2000 Leukemia 14: 255–261

  • Duprez E, Ruchaud S, Houge G, Martin-Thouvenin V, Valensi F, Kastner P, Berger R, Lanotte M . 1992 Leukemia 6: 1281–1287

  • Gianni M, Koken MH, Chelbi-Alix MK, Benoit G, Lanotte M, Chen Z, de Thé H . 1998 Blood 91: 4300–4310

  • Kitamura K, Kiyoi H, Yoshida H, Saito H, Ohno R, Naoe T . 1997 Leukemia 11: 1950–1956

  • Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T . 2000 Leukemia 14: 1743–1750

  • Kizaki M, Fukuchi Y, Ikeda Y . 1999 Int. J. Mol. Med. 4: 359–364

  • Lanotte M, Martin-Thouvenin V, Najman S, Ballerini P, Valensi F, Berger R . 1991 Blood 77: 1080–1086

  • Maksumova L, Ohnishi K, Muratkhodjaev F, Zhang W, Pan L, Takeshita A, Ohno R . 2000 Leukemia 14: 1444–1450

  • Melnick A, Licht JD . 1999 Blood 93: 3167–3215

  • Mologni L, Ponzanelli I, Bresciani F, Sardiello G, Bergamaschi D, Gianni M, Reichert U, Rambaldi A, Terao M, Garattini E . 1999 Blood 93: 1045–1061

  • Nason-Burchenal K, Allopenna J, Begue A, Stehelin D, Dmitrovsky E, Martin P . 1998 Blood 92: 1758–1767

  • Nason-Burchenal K, Maerz W, Albanell J, Allopenna J, Martin P, Moore MA, Dmitrovsky E . 1997 Differentiation 61: 321–331

  • Naito K, Takeshita A, Shigeno K, Nakamura S, Fujisawa S, Shinjo K, Yoshida H, Ohnishi K, Mori M, Terakawa S, Ohno R . 2000 Leukemia 14: 1436–1443

  • Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Segal-Bendirdjian E . 2001 Proc. Natl. Acad. Sci. USA 98: 6662–6667

  • Ponzanelli I, Gianni M, Giavazzi R, Garofalo A, Nicoletti I, Reichert U, Erba E, Rambaldi A, Terao M, Garattini E . 2000 Blood 95: 2672–2682

  • Robertson KA, Emami B, Collins SJ . 1992 Blood 80: 1885–1889

  • Rosenauer A, Raelson JV, Nervi C, Eydoux P, DeBlasio A, Miller Jr WH . 1996 Blood 88: 2671–2682

  • Rowley JD, Golomb HM, Dougherty C . 1977 Lancet 1: 549–550

  • Ruchaud S, Duprez E, Gendron MC, Houge G, Genieser HG, Jastorff B, Doskeland SO, Lanotte M . 1994 Proc. Natl. Acad. Sci. USA 91: 8428–8432

  • Shao W, Benedetti L, Lamph WW, Nervi C, Miller Jr WH . 1997 Blood 89: 4282–4289

  • Shen Y, Shen ZX, Yan H, Chen J, Zeng XY, Li JM, Li XS, Wu W, Xiong SM, Zhao WL, Tang W, Wu F, Liu YF, Niu C, Wang ZY, Chen SJ, Chen Z . 2001 Leukemia 15: 735–741

Download references

Acknowledgements

We thank Drs E Ségal-Bendirdjian, WH Miller, H de Thé, E Garattini and M Chelbi-Alix for their discussion, personal communications, suggestions and/or encouragement to propose this NB4 cell nomenclature. This work was supported by funds from the Institut National de la Santé et de la Recherche Médicale (INSERM) and research grants from the Ligue Nationale contre le Cancer (LNCC) and Association pour la Recherche contre le Cancer (ARC).

Author information

Authors and Affiliations

  1. INSERM U-496, Centre G. Hayem, Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, Paris, 75010, France

    Mathilde J S Roussel & Michel Lanotte

Authors
  1. Mathilde J S Roussel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michel Lanotte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michel Lanotte.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roussel, M., Lanotte, M. Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes. Oncogene 20, 7287–7291 (2001). https://doi.org/10.1038/sj.onc.1204863

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204863

Keywords

This article is cited by

Search

Advanced search

Quick links